Biopsies of liver tissue from 60 patients with NAFLD and 40 healthy controls showed that the levels of the KC activation markers LPS and CD 163 were higher in the former (Hegazy et al., 2020). The gene discussed is CALCA; the disease is metabolic dysfunction-associated steatotic liver disease.